The clinical significance of antinucleolar antibodies

Journal of Clinical Pathology

Volumn 61, Issue 3, 2008, Pages 283-286

  Khan, S ^a,c   Alvi, A ^b   Holding, S ^c   Kemp, M L ^a   Raine, D ^c   Dore P C ^c   Sewell, W A C ^a,d  

^a SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

^b DIANA PRINCESS OF WALES HOSPITAL   (United Kingdom)

^c HULL ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; NUCLEOLUS ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CONNECTIVE TISSUE DISEASE; FEMALE; HUMAN; HUMAN CELL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATIC DISEASE; SCLERODERMA; SCREENING TEST; SYSTEMIC SCLEROSIS;

AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CELL LINE; CONNECTIVE TISSUE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 40449126067     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.049692     Document Type: Article

References (12)